Tatva Chintan Pharma Chem Ltd (TATVA) share fundamentals
Tatva Chintan Pharma Chem Ltd is a small-cap company in Materials (Specialty Chemicals) with a market capitalisation of ₹3,954 crore. Here is where it stands on valuation, profitability, debt and growth as of 5 November 2026, and how it compares with the median Materials company.
Financial health score
Out of 100, across five pillars of reported fundamentals.
What stands out
- Low debt (D/E 0.15x)
- PE of 94x prices in a lot of growth
- Negative free cash flow
- Revenue up 32.3% YoY
Tatva Chintan Pharma Chem Ltd vs the Materials median
| Metric | TATVA | Sector median | |
|---|---|---|---|
| PE ratioprice paid for each rupee of yearly profit | 94.02x | 16.71x | Weaker |
| Price to bookprice against the book value of assets | 5.06x | 1.55x | Weaker |
| EV / EBITDAbusiness value against operating profit | 41.91x | 10.89x | Weaker |
| Dividend yieldyearly dividend as a share of price | 0.1% | 0.7% | Weaker |
| Return on equityprofit on shareholders’ money | 5.5% | 8.4% | Weaker |
| ROCEprofit on all capital employed | 7.6% | 11.1% | Weaker |
| Net profit marginprofit kept from each rupee of sales | 8.3% | 4.1% | Better |
| Debt to equityborrowing against shareholders’ money | 0.15x | 0.32x | Better |
| Interest coveragehow many times profit covers interest | 19.16x | 4.18x | Better |
| Current ratioshort-term assets against short-term dues | 1.64x | 1.7x | In line |
| Revenue growth (1Y)change in sales over a year | 32.3% | 9.5% | Better |
| EPS growth (1Y)change in earnings per share over a year | 636.6% | 9.2% | Better |
| Promoter holdingshare owned by the founders or parent | 72% | 62.2% | Better |
| Promoter pledgepromoter shares pledged as loan security | 0% | 0% | In line |
| Betahow much it moves with the market | 1.22 | 1.05 | |
| 1-year returnshare price change over 52 weeks | 14.3% | -11.6% |
Tell DecideChart your amount, timeline and target return, and AI builds a full A4 report with risks, scenarios and worst cases. Your first report is free.
Other Materials companies
UltraTech Cement LtdULTRACEMCO · score 67.1
JSW Steel LimitedJSWSTEEL · score 75.7
Coal India LimitedCOALINDIA · score 84.4
Hindustan Zinc LtdHINDZINC · score 79.7
Asian Paints LimitedASIANPAINT · score 72.9
Tata Steel LtdTATASTEEL · score 61
Grasim Industries LimitedGRASIM · score 51.2
Hindalco Industries LtdHINDALCO · score 65
Solar Industries India LimitedSOLARINDS · score 79.2
Pidilite Industries LtdPIDILITIND · score 76.8
Vedanta Aluminium Metal LtdVAML · score 32.5
Jindal Steel LtdJINDALSTEL · score 62.8Frequently asked questions
What is the PE ratio of Tatva Chintan Pharma Chem Ltd?
Tatva Chintan Pharma Chem Ltd trades at a PE of 94.02x as of 5 November 2026, against a Materials median of 16.71x. PE is the price paid for each rupee of yearly profit.
Is Tatva Chintan Pharma Chem Ltd debt free?
No. Tatva Chintan Pharma Chem Ltd has a debt-to-equity ratio of 0.15x, against a Materials median of 0.32x.
What is the ROCE and ROE of Tatva Chintan Pharma Chem Ltd?
Tatva Chintan Pharma Chem Ltd has a return on capital employed of 7.6% and a return on equity of 5.5%. The Materials medians are 11.1% and 8.4%.
What is the DecideChart health score of Tatva Chintan Pharma Chem Ltd?
Tatva Chintan Pharma Chem Ltd scores 65.4 out of 100, graded Fair. The score weighs profitability, debt, valuation, growth and governance from the company’s reported numbers. It is a research aid, not a recommendation.
Should I buy Tatva Chintan Pharma Chem Ltd shares?
DecideChart does not give buy or sell tips and is not linked to SEBI, BSE or NSE. Use these numbers for your own research, compare Tatva Chintan Pharma Chem Ltd with its Materials peers, and consult a SEBI-registered adviser before investing.
Fundamentals from a public market-data screener, as of 5 November 2026. Figures can lag company filings. DecideChart is AI-based, not linked to SEBI, BSE or NSE, and does not give investment advice.